Terms: = Head and neck cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Treatment
16 results:
1. Characterization of a Preclinical In Vitro Model Derived from a smarca4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
2. Esophageal carcinoma with smarca4 mutation: Unique diagnostic challenges.
Cui M; Lemmon K; Jin Z; Uboha NV
Pathol Res Pract; 2023 Aug; 248():154692. PubMed ID: 37459679
[TBL] [Abstract] [Full Text] [Related]
3. Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma.
Boiarsky D; Lydon CA; Chambers ES; Sholl LM; Nishino M; Skoulidis F; Heymach JV; Luo J; Awad MA; Janne PA; Van Allen EM; Barbie DA; Vokes NI
Ann Oncol; 2023 Jul; 34(7):589-604. PubMed ID: 37121400
[TBL] [Abstract] [Full Text] [Related]
4. Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Negrao MV; Araujo HA; Lamberti G; Cooper AJ; Akhave NS; Zhou T; Delasos L; Hicks JK; Aldea M; Minuti G; Hines J; Aredo JV; Dennis MJ; Chakrabarti T; Scott SC; Bironzo P; Scheffler M; Christopoulos P; Stenzinger A; Riess JW; Kim SY; Goldberg SB; Li M; Wang Q; Qing Y; Ni Y; Do MT; Lee R; Ricciuti B; Alessi JV; Wang J; Resuli B; Landi L; Tseng SC; Nishino M; Digumarthy SR; Rinsurongkawong W; Rinsurongkawong V; Vaporciyan AA; Blumenschein GR; Zhang J; Owen DH; Blakely CM; Mountzios G; Shu CA; Bestvina CM; Garassino MC; Marrone KA; Gray JE; Patel SP; Cummings AL; Wakelee HA; Wolf J; Scagliotti GV; Cappuzzo F; Barlesi F; Patil PD; Drusbosky L; Gibbons DL; Meric-Bernstam F; Lee JJ; Heymach JV; Hong DS; Heist RS; Awad MM; Skoulidis F
Cancer Discov; 2023 Jul; 13(7):1556-1571. PubMed ID: 37068173
[TBL] [Abstract] [Full Text] [Related]
5. smarca4/brg1-Deficient Sinonasal Carcinoma.
Kakkar A; Ashraf SF; Rathor A; Adhya AK; Mani S; Sikka K; Jain D
Arch Pathol Lab Med; 2022 Sep; 146(9):1122-1130. PubMed ID: 34871352
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma.
Ohmoto A; Sato Y; Asaka R; Fukuda N; Wang X; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Toshiyasu T; Mitani H; Takeuchi K; Mori S; Takahashi S
Mod Pathol; 2021 Nov; 34(11):1979-1989. PubMed ID: 34247193
[TBL] [Abstract] [Full Text] [Related]
7. Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies.
de Klerk LK; Goedegebuure RSA; van Grieken NCT; van Sandick JW; Cats A; Stiekema J; van der Kaaij RT; Farina Sarasqueta A; van Engeland M; Jacobs MAJM; van Wanrooij RLJ; van der Peet DL; Thorner AR; Verheul HMW; Thijssen VLJL; Bass AJ; Derks S
Mol Oncol; 2021 Apr; 15(4):901-914. PubMed ID: 33506581
[TBL] [Abstract] [Full Text] [Related]
8. Verrucous esophageal carcinoma is a unique indolent subtype of squamous cell carcinoma: a systematic review and individual patient regression analysis.
Li DK; Haffar S; Horibe M; Homsi HA; Zukerberg L; Murad MH; Visrodia KH; Gala M; Katzka DA; Bazerbachi F
J Gastroenterol; 2021 Jan; 56(1):12-24. PubMed ID: 33079233
[TBL] [Abstract] [Full Text] [Related]
9. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
[TBL] [Abstract] [Full Text] [Related]
10. smarca4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract] [Full Text] [Related]
11. Anticariogenic efficacy of a saliva biomimetic in head-and-neck cancer patients undergoing radiotherapy.
Sim C; Walker GD; Manton DJ; Soong YL; Wee J; Adams GG; Reynolds EC
Aust Dent J; 2019 Mar; 64(1):47-54. PubMed ID: 30341773
[TBL] [Abstract] [Full Text] [Related]
12. Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer.
Lissanu Deribe Y; Sun Y; Terranova C; Khan F; Martinez-Ledesma J; Gay J; Gao G; Mullinax RA; Khor T; Feng N; Lin YH; Wu CC; Reyes C; Peng Q; Robinson F; Inoue A; Kochat V; Liu CG; Asara JM; Moran C; Muller F; Wang J; Fang B; Papadimitrakopoulou V; Wistuba II; Rai K; Marszalek J; Futreal PA
Nat Med; 2018 Jul; 24(7):1047-1057. PubMed ID: 29892061
[TBL] [Abstract] [Full Text] [Related]
13. Frameshift events predict anti-PD-1/L1 response in head and neck cancer.
Hanna GJ; Lizotte P; Cavanaugh M; Kuo FC; Shivdasani P; Frieden A; Chau NG; Schoenfeld JD; Lorch JH; Uppaluri R; MacConaill LE; Haddad RI
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467336
[TBL] [Abstract] [Full Text] [Related]
14. Erratum to "Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study".
Chambers MS; Fleming TJ; Toth BB; Lemon JC; Craven TE; Bouwsma OJ; Garden AS; Espeland MA; Keene HJ; Martin JW; Sipos T
Oral Oncol; 2007 Jan; 43(1):98-105. PubMed ID: 18027401
[TBL] [Abstract] [Full Text] [Related]
15. Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study.
Chambers MS; Mellberg JR; Keene HJ; Bouwsma OJ; Garden AS; Sipos T; Fleming TJ
Oral Oncol; 2006 Oct; 42(9):946-53. PubMed ID: 16757200
[TBL] [Abstract] [Full Text] [Related]
16. A comparison of the effectiveness of two systems for the prevention of radiation caries.
Al-Joburi W; Clark C; Fisher R
Clin Prev Dent; 1991; 13(5):15-9. PubMed ID: 1809524
[TBL] [Abstract] [Full Text] [Related]
